
Journal of Biomedical Materials Research Part A, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 17, 2024
ABSTRACT Nanoparticles are increasingly being used in the development of vaccines for disease prevention or treatment. Recent research has demonstrated that conjugating a protein onto surface nanoparticles can significantly increase its immunogenicity. Considering various pathogens threaten human health, multivalent often desirable. Up to now, nanoparticle‐based mostly limited one per nanoparticle. No been conducted explore possibility more than Here we developed specific conjugation strategy conjugate multiple proteins PLGA/lipid hybrid nanoparticle surface. The maleimide‐thiol Michael addition, Aizde‐DBCO (Dibenzocyclooctyne), and TCO (trans‐cycloctene)‐Tetrazine click chemistry were employed three different proteins, subunit keyhole limpet hemocyanin (sKLH), Ovalbumin (OVA), cross‐reactive material 197 (CRM ), (hNPs). successful results this study pave way developing against pathogens.
Language: Английский